Hemostasis treatment type | Pooled risk of gastric varices rebleeding (confidence interval) | Pooled risk of esophageal varices rebleeding (confidence interval) |
---|---|---|
Cyanoacrylate alone | 0.15 (0.11–0.18) | 0.29 (0.11–0.47) |
Cyanoacrylate combined with ethanolamine | 0.08 (0.02–0.14) | 0.02 (− 0.02–0.05). |
Cyanoacrylate combined with endoscopic ultrasound guided coils | 0.07 (0.03–0.11) | – |
Cyanoacrylate combined with percutaneous transhepatic variceal embolization | 0.10 (0.03–0.17) a | 0.16 (0.10–0.22) |
Cyanoacrylate combined with transjugular intrahepatic portosystemic shunt | – | 0.06(−0.01–0.12) a |
Cyanoacrylate combined with sclerotherapy | 0.10 (0.05–0.18) a | 0.12 (0.04–0.20) a. |
Cyanoacrylate combined with band ligation | – | 0.10 (0.04–0.24) a |
Cyanoacrylate combined with polidocanol | 0.10 (0.02–0.19) a | – |
Cyanoacrylate combined with lipiodol | 0.13 (0.03–0.22) a | – |
Cyanoacrylate combined with balloon-occluded retrograde transvenous obliteration | 0.31 (0.13–0.49) b |